Nath Bio-Genes (India) Ltd.
NSE: NATHBIOGEN | BSE: 537291
₹158.30
₹-2.62
(-1.63%)
As on 18-May-2026IST
Market cap
₹301 Cr
Revenue (TTM)
₹445 Cr
P/E Ratio
7.2
P/B Ratio
0.4
Div. Yield
1.3 %
Quality Score
1/10
Growth Score
2/10
Valuation Score
7/10
Momentum Score
8/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹42 Cr
-
ROE
6.2 %
-
ROCE
6.9 %
-
Industry P/E
15.73
-
EV/EBITDA
6
-
Debt to Equity
0
-
Book Value
₹358.1
-
EPS
₹19.9
-
Face value
10
-
Shares outstanding
19,004,000
10 Years Aggregate
CFO
₹77.98 Cr
EBITDA
₹445.14 Cr
Net Profit
₹250.29 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Nath Bio-Genes
| 1.8 | -5.6 | 6.5 | -15.2 | -1.3 | -18.2 | 5.5 |
|
BSE FMCG
| -7.1 | 2.0 | -1.4 | -9.9 | 1.8 | 7.6 | 9.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Nath Bio-Genes
| -17.7 | -12.1 | 28.4 | -38.9 | -3.0 | -25.7 | -18.4 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE FMCG
| -2.1 | 1.5 | 27.3 | 16.6 | 9.3 | 10.5 | -3.6 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Nath Bio-Genes
|
158.3 | 301.2 | 445.1 | 41.6 | 10.9 | 5.6 | 7.2 | 0.4 |
| 126.0 | 1,304.2 | 2,001.7 | 60.8 | -- | 17.6 | 12.6 | 1.5 | |
| 260.5 | 1,307.3 | 1,378.9 | 101.1 | 9.9 | 13.5 | 12.9 | 1.8 | |
| 169.5 | 3,524.6 | 1,463.4 | 73.6 | 6.1 | 16.3 | 48 | 6.8 | |
| 219.0 | 264.9 | 493.3 | 4.4 | 0.5 | 2.7 | 64 | 1.6 | |
| 932.1 | 4,791.3 | 1,377.9 | 300.8 | 20.1 | 18.3 | 15.9 | 2.6 | |
| 404.6 | 14,046.4 | 10,945.6 | 619.5 | 8.3 | 14.4 | 22.5 | 3.1 | |
| 4.2 | 456.9 | 1,440.2 | 343.1 | 24.1 | 32.2 | 1.3 | 0.4 | |
| 296.7 | 329.3 | 14.1 | 1.1 | 7.5 | 18.1 | 311.3 | 47.7 | |
| 3.6 | 451.2 | 1,312.7 | 33.1 | 5.1 | 8.6 | 13.7 | 0.9 |
Shareholding Pattern
View DetailsNews & Analysis
All News
1 min read•By Research Desk
About Nath Bio-Genes
Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers fiber and oil... seeds, including cotton and mustard; seeds for field crops, such as bajra, corn, paddy, wheat, and jowar; fruit seeds; and seeds for vegetables comprising cabbage, chilli, onion, okra, tomato, brinjal, bottle gourd, bitter gourd, sponge gourd, ridge gourd, cucumber, coriander, sweet pepper, green peas, pumpkin, tinda, and French beans. It also provides crop protection supplements under the WINPro GOLii, WINall, and Win-Chi-Win names; and forage seeds under the NUTRIMAX GOLD and NUTRIMAX names. The company was founded in 1979 and is based in Mumbai, India. Read more
-
Incorporated
2000
-
Chairman
--
-
Managing Director
Satish Kagliwal
-
Headquarters
Chhatrapati Sambhajinagar - (Aurangabad), Maharashtra
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsFAQs for Nath Bio-Genes
What is the current share price of Nath Bio-Genes (India) Ltd Today?
The share price of Nath Bio-Genes (India) Ltd is ₹158.30 (NSE) and ₹158.50 (BSE) as of 18-May-2026 IST. Nath Bio-Genes (India) Ltd has given a return of -1.32% in the last 3 years.
What is the current PB & PE ratio of Nath Bio-Genes (India) Ltd?
The P/E ratio of Nath Bio-Genes (India) Ltd is 7.24 times as on 18-May-2026, a 54 discount to its peers’ median range of 15.73 times.
The P/B ratio of Nath Bio-Genes (India) Ltd is 0.44 times as on 18-May-2026, a 76 discount to its peers’ median range of 1.87 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
7.18
|
0.43
|
|
2024
|
8.33
|
0.54
|
|
2023
|
7.69
|
0.47
|
|
2022
|
0.00
|
0.75
|
|
2021
|
10.24
|
0.93
|
What is the 52 Week High and Low of Nath Bio-Genes (India) Ltd?
The 52-week high and low of Nath Bio-Genes (India) Ltd are Rs 238.69 and Rs 126.15 as of 19-May-2026.
What is the market cap of Nath Bio-Genes (India) Ltd?
Nath Bio-Genes (India) Ltd has a market capitalisation of ₹ 301 Cr as on 18-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Nath Bio-Genes (India) Ltd?
Before investing in Nath Bio-Genes (India) Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.